PRMT1 and intestinal cancer: Crossing these mice with intestine-specific Villin-Cre or tumor-developing Apcmin mice, could be an elegant way to further study the role of PRMT1 in IEC differentiation and maturation and to investigate the therapeutic potential of PRMT1 inhibition for the treatment of intestinal cancer.